CMRC raised its full-year operating income guidance from $22M to $27.2M, alongside improved GAAP and non-GAAP gross margins. Despite this significant increase in profitability outlook, the stock continues to trade at 1x ARR, suggesting it may be undervalued. Investors should consider this positive revision and current valuation.